Evaluating the Effects of Inarigivir on Immune Response and Viral Markers in Chronic Hepatitis B Patients
Clinical trial NCT03932513 · TERMINATED
Trial details
- NCT number
- NCT03932513
- Sponsor
- F-star Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2019-12-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.